Emcure Pharmaceuticals to Acquire 20.42% Stake in Subsidiary Zuventus Healthcare, Making it a Wholly-Owned Subsidiary

Emcure Pharmaceuticals Ltd. has approved the acquisition of 4,095,180 Equity Shares, constituting 20.42% of the total issued and paid-up capital of Zuventus Healthcare Limited, a subsidiary of the Company. This acquisition will make Zuventus a wholly-owned subsidiary of Emcure. The acquisition is expected to be completed on or before September 30, 2025, with a cash consideration of Rs. 7,249 Millions. Post-acquisition, Emcure's shareholding in Zuventus will increase to 100% from the current 79.58%.